BEAM
Beam Therapeutics Inc
24.80$
-1.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +12,616.7% | +6,593.2% | -83.5% | +97.5% | -5.1% | +26.8% | +20.8% | -16.9% | -14.5% | +1,739.1% | -97.7% | +58.9% | +21.2% | +110.7% | -75.2% | +13.3% | +14.6% | +1,076.6% | -72.2% | -98.5% | – | |
| – | +0.0% | -11.7% | +115.1% | -31.8% | +38.1% | -1.1% | +61.2% | +6.6% | -10.2% | +54.1% | +8.8% | +485.8% | -76.0% | +19.8% | -206.5% | – | +14.0% | +14.4% | +1.2% | +15.4% | -2.0% | +2.5% | +40.0% | -39.4% | +2.6% | +8.3% | +7.6% | -2.6% | +3.0% | +7.9% | -94.8% | +95.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -152.2% | – | – | – | – | – | – | – | -144.0% | – | – | – | – | – | – | – | -80.9% | -97.6% | – | |
| – | +0.0% | +39.1% | 0.0% | -6.8% | +38.1% | -1.1% | +61.2% | +6.6% | -10.2% | +54.1% | +8.8% | +485.8% | -76.0% | +19.8% | +77.2% | -32.4% | +14.0% | +14.4% | +1.2% | +15.4% | -2.0% | +2.5% | +40.0% | -39.4% | +2.6% | +8.3% | +7.6% | -2.6% | +3.0% | +7.9% | -9.6% | +5.3% | -9.0% | – | |
| – | +0.0% | +6.5% | +30.9% | +5.9% | +26.7% | +10.2% | +12.3% | +10.6% | +1.8% | +8.1% | +11.4% | +23.0% | +30.5% | +17.7% | +12.7% | +8.3% | +25.0% | -9.3% | +4.0% | +3.6% | +5.0% | +3.1% | +70.2% | -38.2% | +10.9% | -10.5% | +8.1% | -2.5% | -3.9% | -0.4% | -0.5% | +29.4% | -7.2% | – | |
| – | +0.0% | +141.7% | -98.3% | +3,439.6% | +26.7% | +10.2% | +12.3% | +10.6% | +1.8% | +8.1% | +11.4% | +23.0% | +30.5% | +17.7% | +995.0% | -88.9% | +25.0% | -9.3% | +4.0% | +3.6% | +5.0% | +3.1% | +70.2% | -38.2% | +10.9% | -10.5% | +8.1% | -2.5% | -3.9% | -0.4% | +370.8% | +1.6% | -0.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -178.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +70.0% | +401.7% | -13.4% | -67.3% | +827.8% | -98.7% | +147.6% | -82.7% | +0.0% | +7,055.6% | +219.9% | +141.8% | +52.8% | +30.9% | +20.0% | +6.2% | -5.0% | – | – | -14.5% | – | – | – | -11.5% | -2.4% | -7.3% | -24.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -168.4% | – | – | – | – | – | – | – | -138.6% | – | – | |
| – | +0.0% | -5,687.5% | – | -99.2% | -58.2% | +367.1% | -94.4% | +3,723.6% | +277.2% | -151.5% | – | -98.4% | +1,859.1% | -340.3% | – | – | – | – | -58.5% | -1,342.9% | – | – | – | +294.4% | -99.3% | -14,138.5% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -169.1% | – | – | – | – | – | – | – | -138.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -170.0% | – | – | – | – | – | – | – | -162.4% | – | – | – | – | – | – | – | -134.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.